Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of AMGEN Inc (NASDAQ: AMGN) closed at $329.89 in the last session, down -3.02% from day before closing price of $340.16. In other words, the price has decreased by -$3.02 from its previous closing price. On the day, 2.89 million shares were traded. AMGN stock price reached its highest trading level at $340.87 during the session, while it also had its lowest trading level at $328.63.
Ratios:
We take a closer look at AMGN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.39. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 5.67 whereas as Long-Term Debt/Eq ratio is at 5.45.
On November 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $385.Scotiabank initiated its Sector Outperform rating on November 13, 2025, with a $385 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 20 ’25 when Grygiel Nancy A. sold 3,139 shares for $337.26 per share. The transaction valued at 1,058,667 led to the insider holds 7,225 shares of the business.
Grygiel Nancy A. bought 3,139 shares of AMGN for $1,058,667 on Nov 20 ’25. On Nov 12 ’25, another insider, Khosla Rachna, who serves as the SVP, Business Development of the company, sold 890 shares for $336.24 each. As a result, the insider received 299,256 and left with 7,082 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 177639391232 and an Enterprise Value of 222781390848. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.50, and their Forward P/E ratio for the next fiscal year is 15.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.95 while its Price-to-Book (P/B) ratio in mrq is 18.47. Its current Enterprise Value per Revenue stands at 6.193 whereas that against EBITDA is 13.517.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.45, which has changed by 0.18823612 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $346.38, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is 5.74%, while the 200-Day Moving Average is calculated to be 11.18%.
Shares Statistics:
According to the various share statistics, AMGN traded on average about 2.63M shares per day over the past 3-months and 2841350 shares per day over the past 10 days. A total of 538.50M shares are outstanding, with a floating share count of 537.46M. Insiders hold about 0.19% of the company’s shares, while institutions hold 81.33% stake in the company. Shares short for AMGN as of 1763078400 were 13363223 with a Short Ratio of 5.09, compared to 1760486400 on 11478293. Therefore, it implies a Short% of Shares Outstanding of 13363223 and a Short% of Float of 2.4899999999999998.
Dividends & Splits
The forward annual dividend rate for AMGN is 9.52, which was 9.39 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.027604658. The stock’s 5-year Average Dividend Yield is 3.06. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-11-21 with an ex-dividend date of 2025-11-21. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
The company has 25.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $5.06, with high estimates of $6.55 and low estimates of $4.41.
Analysts are recommending an EPS of between $22.3 and $20.6 for the fiscal current year, implying an average EPS of $21.24. EPS for the following year is $21.86, with 31.0 analysts recommending between $24.49 and $20.33.
Revenue Estimates
According to 22 analysts,. The current quarter’s revenue is expected to be $9.46B. It ranges from a high estimate of $9.87B to a low estimate of $8.98B. As of. The current estimate, AMGEN Inc’s year-ago sales were $9.09BFor the next quarter, 22 analysts are estimating revenue of $8.66B. There is a high estimate of $8.97B for the next quarter, whereas the lowest estimate is $8.22B.
A total of 28 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.76B, while the lowest revenue estimate was $35.87B, resulting in an average revenue estimate of $36.33B. In the same quarter a year ago, actual revenue was $33.42BBased on 31 analysts’ estimates, the company’s revenue will be $36.85B in the next fiscal year. The high estimate is $38.74B and the low estimate is $35.3B.
